Tirzepatide is a synthetic peptide that functions as a dual agonist for the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) receptors. This combination enhances insulin secretion, suppresses glucagon release, delays gastric emptying, and reduces appetite, making it a subject of interest in metabolic research.
Tirzepatide is primarily utilized in scientific studies focusing on:
Tirzepatide is intended strictly for laboratory research and is not approved for human consumption. Handle with care, following appropriate safety protocols. Ensure proper storage conditions to maintain the integrity and efficacy of the compound.
Have questions about our peptides or need personalized guidance? Send us a message through the form below, and we’ll respond promptly to help you make informed choices with confidence.